0001209191-23-056794.txt : 20231128
0001209191-23-056794.hdr.sgml : 20231128
20231128162356
ACCESSION NUMBER: 0001209191-23-056794
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231127
FILED AS OF DATE: 20231128
DATE AS OF CHANGE: 20231128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chin Mark
CENTRAL INDEX KEY: 0001734389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38800
FILM NUMBER: 231446770
MAIL ADDRESS:
STREET 1: 20 BERKELEY SQUARE, MAYFAIR
CITY: LONDON
STATE: X0
ZIP: W1J 6EQ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708493
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473458693
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 443-7400
MAIL ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-27
0
0001708493
Harpoon Therapeutics, Inc.
HARP
0001734389
Chin Mark
C/O HARPOON THERAPEUTICS, INC.
611 GATEWAY BOULEVARD, SUITE 400
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Common Stock
2023-11-27
4
A
0
5000
0.00
A
11729
D
Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 25% of the RSUs will vest on each May 27th and November 27th of 2024 and 2025, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing employment of the Reporting Person on each vesting date.
/s/ Frank J. Lanza, Attorney-in-Fact
2023-11-28